Page 2 of Ranbaxy Laboratories

Sun Pharmaceutical wins US approval to buy Ranbaxy

Ranbaxy has been involved in a wrangle with the US FDA, which has barred a range of its medicines from…

January 31, 2015 08:27 IST

Ranbaxy Laboratories, Ranbaxy Laboratories december quarter profit, Ranbaxy profit, Ranbaxy net profit

Ranbaxy Laboratories December quarter net loss widens to Rs 1,029 cr on forex woes

Ranbaxy Laboratories today reported widening of its consolidated net loss to Rs 1,029.72 crore for the third quarter ended…

January 28, 2015 18:20 IST

CCI approves Ranbaxy acquisition by Sun Pharma

Sun Pharma and Ranbaxy had filed the notice with the CCI on May 6, 2014 and sought its approval with…

December 22, 2014 15:47 IST

Deal clincher: Sun hoists its flag on domestic pharma landscape

Competition Commission has asked Sun Pharma to divest one drug and Ranbaxy six over the next six months to ensure…

December 15, 2014 00:48 IST

India’ Sun Pharma, Ranbaxy gain after regulator approves deal

Sun Pharmaceutical Industries gains 2.9 pct, Ranbaxy Laboratories up 3.7 pct.

December 9, 2014 11:32 IST

CCI clears Sun Pharma-Ranbaxy Laboratorie merger, subject to divesting seven brands

The Competition Commission of India cleared the $3.2-billion Sun Pharmaceutical Industries’ purchase of Ranbaxy Laboratories…

December 9, 2014 00:38 IST

CCI clears $4-bn Sun Pharmaceutical, Ranbaxy Laboratories merger deal, but adds riders

The long-pending $4-billion merger between Sun Pharmaceuticals and Ranbaxy Laboratories today…

Updated: December 8, 2014 21:47 IST

AstraZeneca, Ranbaxy Laboratories prevail, Nexium drug deal ‘not anti-competitive’

In a landmark judgement for pharma sector, a US jury has ruled that AstraZeneca’s patent litigation settlement for blockbuster drug…

Updated: December 6, 2014 21:52 IST

RSSDI and Ranbaxy join hands to help juvenile diabetes patients

507 doctors came together to create a blue circle, the universal symbol of diabetes to spread awareness

Updated: December 8, 2014 11:32 IST

German ban on Ranbaxy’s Dewas product expands to entire EU

Adding to Ranbaxy’s regulatory troubles overseas, certain drugs produced at its Dewas plant have been barred from export…

December 5, 2014 06:22 IST

Germany bars Ranbaxy’s antibiotic drug from Dewas plant

The regulator found deficiencies related to operation of drug manufacturing rooms and procedures related to sterilisation of equipment at the…

Updated: December 4, 2014 18:10 IST

Germany bans Ranbaxy drug

Ranbaxy Laboratories has been barred from exporting the antibiotic cephalosporin to Germany…

December 4, 2014 04:18 IST

Now, Ranbaxy Laboratories’ Dewas plant drugs banned by Germany

In fresh overseas troubles, drugmaker Ranbaxy Laboratories has been barred…

December 3, 2014 21:42 IST

Ranbaxy launches India’s first biosimilar of Infliximab drug, Infimab

The clinical effectiveness of Infimab, coupled with cost-effective pricing and a patient support programme, will enable more patients to get…

Updated: December 1, 2014 15:07 IST

RSSDI and Ranbaxy join hands to help juvenile diabetes patients

507 doctors came together to create a blue circle, the universal symbol of diabetes to spread awareness

November 24, 2014 13:05 IST

RSSDI and Ranbaxy join hands to help juvenile diabetes patients

507 doctors came together to create a blue circle, the universal symbol of diabetes to spread awareness

Updated: November 24, 2014 13:00 IST

US court overturns bid by Ranbaxy to block launch of rival generic drugs

A U.S. court has denied a request by Indian drugmaker Ranbaxy Laboratories Ltd…

November 20, 2014 14:11 IST

Ranbaxy sues US FDA over revoking drug approvals

US regulator rescinds approval to generics Valcyte & Nexium

November 19, 2014 04:11 IST

Related News

Aadhaar rule change 2025: New UIDAI update fees, PAN-Aadhaar link and KYC rules explained

Aadhaar rule change 2025: New UIDAI update fees, PAN-Aadhaar linking and KYC rules explained

‘Worship of false gods’: MAGA spreads hate on Diwali as Trump lights diyas at White House

WinTrack highlighted a case of an entrepreneur allegedly harassed by customs at Indira Gandhi International Airport in Delhi, stressing that “genuine entrepreneurs face harassment frequently”.

‘Reccuring problem at Indian airports’: Wintrack highlights case of entrepreneur harassed by customs at Delhi Airport

F-1 visa denied for applicant after single question at US Consulate

Stepping inside Parineeti Chopra and Raghav Chadha’s dreamy homes, where luxury and warmth reside together

Mutual funds trim small-cap bets as institutional flows chase large caps

Money51 min ago

Mutual funds trimmed small-cap exposure as institutional flows from EPFO, NPS, insurance funds, and AIFs chased large-cap stocks, Jefferies said in its latest India equities report. While SIP inflows stayed strong and domestic equity flows steady, fund managers booked profits amid stretched small-cap valuations.

View all shorts